BIOMAT Database Logo BIOMAT Database Logo

Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. 1993

C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Karolinska Institute, Department of Medicine, Huddinge University Hospital, Sweden.

OBJECTIVE A disturbed energy transfer involving the adenine nucleotide translocator across the inner mitochondrial membrane has been suggested to be one specific pathogenetic mechanism in dilated cardiomyopathy. Pretranslational steady state expression of this protein in dilated cardiomyopathy was investigated. METHODS Concentrations of adenine nucleotide translocator were quantified by solution hybridisation. The enzyme or protein expressions of citrate synthase, lactate dehydrogenase, and creatine kinase with isozymes were determined. Analysis was performed on specimens from the left and right ventricles from six organ donor hearts, six explanted hearts with dilated cardiomyopathy, two explanted hearts with ischaemic cardiomyopathy, and from papillary muscles from seven patients operated on for mitral regurgitation. RESULTS The ejection fraction in patients with mitral regurgitation was 50(10)%, significantly higher (p < 0.001) than in patients with dilated cardiomyopathy (23(5))%. In mitral regurgitation and in ischaemic cardiomyopathy left ventricular adenine nucleotide translocator mRNA concentrations did not differ from those in donor hearts. In dilated cardiomyopathy, adenine nucleotide translocator mRNA concentrations were significantly increased (p < 0.001). Upregulation was more pronounced in right ventricular than in left ventricular myocardium (p < 0.01). The lactate dehydrogenase M subunit fraction was increased to a similar degree in dilated cardiomyopathy and in mitral regurgitation (p < 0.05). Citrate synthase activity was significantly decreased only in dilated cardiomyopathy (p < 0.005). On the other hand, the creatine kinase B subunit content was significantly higher in mitral regurgitation than in dilated cardiomyopathy (p < 0.001). CONCLUSIONS Despite signs of increased anaerobic and depressed oxidative capacities, dilated cardiomyopathy was specifically characterised by pretranslational upregulation of adenine nucleotide translocator.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D002950 Citrate (si)-Synthase Enzyme that catalyzes the first step of the tricarboxylic acid cycle (CITRIC ACID CYCLE). It catalyzes the reaction of oxaloacetate and acetyl CoA to form citrate and coenzyme A. This enzyme was formerly listed as EC 4.1.3.7. Citrate Synthase,Synthase, Citrate
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females

Related Publications

C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function.
September 1997, Molecular and cellular biochemistry,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Study of autoantibodies against the adenine nucleotide translocator in idiopathic dilated cardiomyopathy.
January 1996, Blood pressure. Supplement,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy.
May 2000, Herz,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy.
June 1985, Journal of molecular and cellular cardiology,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Adenine nucleotide translocator in heart.
January 2000, Molecular genetics and metabolism,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis--incidence and relation to cardiac function and morphology.
December 1993, Japanese circulation journal,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
The mitochondrial adenine nucleotide translocator.
February 1976, Journal of bioenergetics,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
The adenine nucleotide translocator in apoptosis.
January 2002, Biochimie,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy.
January 1985, Advances in myocardiology,
C Sylvén, and L Lin, and E Jansson, and P Sotonyi, and L X Fu, and F Waagstein, and A Hjalmarsson, and C Marcus, and M Brönnegård
Is the adenine nucleotide translocator rate-limiting for oxidative phosphorylation?
May 1978, The Biochemical journal,
Copied contents to your clipboard!